284 related articles for article (PubMed ID: 14523488)
21. Drug-induced long QT syndrome and torsade de pointes.
Morissette P; Hreiche R; Turgeon J
Can J Cardiol; 2005 Aug; 21(10):857-64. PubMed ID: 16107909
[TBL] [Abstract][Full Text] [Related]
22. Torsade de pointe. Report of 18 cases.
Chalak W; Taha A; Araoya M; Rifaat M
J Med Liban; 1993; 41(2):62-8; discussion 68-9. PubMed ID: 8057345
[TBL] [Abstract][Full Text] [Related]
23. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias.
Topilski I; Rogowski O; Rosso R; Justo D; Copperman Y; Glikson M; Belhassen B; Hochenberg M; Viskin S
J Am Coll Cardiol; 2007 Jan; 49(3):320-8. PubMed ID: 17239713
[TBL] [Abstract][Full Text] [Related]
24. Ciprofloxacin-induced torsade de pointes.
Flanagan MC; Mitchell ES; Haigney MC
Int J Cardiol; 2006 Nov; 113(2):239-41. PubMed ID: 16386810
[TBL] [Abstract][Full Text] [Related]
25. [Torsade de pointes (TdP) observed during general anesthesia for cerebral aneurysm clipping in a patient with QT prolongation].
Tajiri O; Ito H; Yago Y; Masumori Y
Masui; 2011 Sep; 60(9):1090-3. PubMed ID: 21950044
[TBL] [Abstract][Full Text] [Related]
26. Torsades de Pointes with QT prolongation related to donepezil use.
Takaya T; Okamoto M; Yodoi K; Hata K; Kijima Y; Nakajima H; Nishikawa Y; Kita T; Ito M; Seo T; Kawashima S
J Cardiol; 2009 Dec; 54(3):507-11. PubMed ID: 19944332
[TBL] [Abstract][Full Text] [Related]
27. Torsade de pointes in Kearns-Sayre syndrome.
Wilmin S; De Bels D; Knecht S; Gottignies P; Gazagnes MD; Devriendt J
Pract Neurol; 2012 Jun; 12(3):199-201. PubMed ID: 22661355
[TBL] [Abstract][Full Text] [Related]
28. [Short coupled variant of torsade de pointes: our experience and review of the literature].
Fehri W; Abdessalem S; Smiri Z; Mhenni H; Barakett N; Rahal N; Haouala H
Tunis Med; 2004 Sep; 82(9):867-74. PubMed ID: 15693481
[TBL] [Abstract][Full Text] [Related]
29. Neonatal life-threatening arrhythmia responding to lidocaine, a probable LQTS3.
Betrián Blasco P; Antúnez Jiménez MI; Falcón González LH; Suárez Cabrera P
Int J Cardiol; 2007 Apr; 117(2):e61-3. PubMed ID: 17320211
[TBL] [Abstract][Full Text] [Related]
30. Methadone-induced torsade de pointes in a patient with normal baseline QT interval.
Almehmi A; Malas AM; Yousufuddin M; Rosencrance JG
W V Med J; 2004; 100(4):147-8. PubMed ID: 15471174
[TBL] [Abstract][Full Text] [Related]
31. Life-threatening Torsades de Pointes resulting from "natural" cancer treatment.
Chan CK; Chan MH; Tse ML; Chan IH; Cheung RC; Lam CW; Lau FL
Clin Toxicol (Phila); 2009 Jul; 47(6):592-4. PubMed ID: 19586358
[TBL] [Abstract][Full Text] [Related]
32. Sulpiride induced torsade de pointes.
Huang BH; Hsia CP; Chen CY
Int J Cardiol; 2007 Jun; 118(3):e100-2. PubMed ID: 17408770
[TBL] [Abstract][Full Text] [Related]
33. [Anti-arrhythmic action of magnesium sulfate in "torsade de pointes" ventricular arrhythmia].
Bolognesi R; Tsialtas D; Cortesi G; Pela G; Manca C
G Ital Cardiol; 1984 Dec; 14(12):1077-80. PubMed ID: 6532886
[TBL] [Abstract][Full Text] [Related]
34. [Short coupled variant of "torsades de pointes" and sudden death].
Hentati M; Krichene S; Kechida Z; Chahbani I; Hached L; Grati Z; Charfeddine H; Kammoun S
Tunis Med; 2004 Jun; 82(6):542-5. PubMed ID: 15517954
[TBL] [Abstract][Full Text] [Related]
35. Q-T interval prolongation and pleomorphic ventricular tachyarrhythmia ('Torsade de pointes') in organophosphate poisoning: report of a case.
Wang MH; Tseng CD; Bair SY
Hum Exp Toxicol; 1998 Oct; 17(10):587-90. PubMed ID: 9821023
[TBL] [Abstract][Full Text] [Related]
36. Drug therapy for torsade de pointes.
Banai S; Tzivoni D
J Cardiovasc Electrophysiol; 1993 Apr; 4(2):206-10. PubMed ID: 8269292
[TBL] [Abstract][Full Text] [Related]
37. Torsade de pointes in a patient with complex medical and psychiatric conditions receiving low-dose quetiapine.
Vieweg WV; Schneider RK; Wood MA
Acta Psychiatr Scand; 2005 Oct; 112(4):318-22; author reply 322. PubMed ID: 16156840
[TBL] [Abstract][Full Text] [Related]
38. QT interval prolongation and ventricular fibrillation in childhood end-stage renal disease.
Kim GB; Cho HY; Kwon BS; Bae EJ; Noh CI; Choi JY; Yun YS; Choi Y; Ha JW
Int J Cardiol; 2008 Jul; 127(3):e126-8. PubMed ID: 17714808
[TBL] [Abstract][Full Text] [Related]
39. [Polymorph ventricular tachycardia with torsades de pointes caused by administration of terodiline (Mictrol)].
van der Klauw MM; van Rey FJ; Stricker BH
Ned Tijdschr Geneeskd; 1992 Jan; 136(2):91-3. PubMed ID: 1370730
[TBL] [Abstract][Full Text] [Related]
40. Sustained torsade de pointes occurring early during oral sotalol therapy for atrial fibrillation recurrence prophylaxis in a patient without heart disease.
D'Aloia A; Faggiano P; Brentana L; Boldini A; Pedrinazzi C; Procopio R; Dei Cas L
Int J Cardiol; 2005 Dec; 105(3):337-9. PubMed ID: 15985302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
